Principal

DecisionPoint Systems to Go Private in All-Cash Transaction

Retrieved on: 
Mittwoch, Mai 1, 2024
Networks, Internet, Data Management, Technology, Software, Dechert, Polsinelli, LLP, Investment, Proxy, Principal, Cole, Printing, Capital Group Companies, Organization

Steve Smith, CEO of DecisionPoint, commented: “I’m excited by the prospects of teaming up with Barcoding for the next phase in DecisionPoint’s growth.

Key Points: 
  • Steve Smith, CEO of DecisionPoint, commented: “I’m excited by the prospects of teaming up with Barcoding for the next phase in DecisionPoint’s growth.
  • Today’s announcement to be taken private for $10.22 in cash per share is a capstone for our public shareholders.
  • The transaction is currently expected to close in July 2024, subject to the approval of DecisionPoint stockholders and the satisfaction of customary closing conditions.
  • Upon completion of the transaction, DecisionPoint will become a privately held company and its stock will no longer be publicly traded.

Financial Services Law Firm Mitchell Sandler Celebrates Five Year Milestone: Expands Fair Lending Practice with Former Senior DOJ Official Jon Seward and Nationally Recognized Financial Services Litigator Olivia Kelman

Retrieved on: 
Mittwoch, Mai 1, 2024
Professional Services, Business, Legal, Finance, Consulting, Banking, Bias, Private practice, Justice, Growth, K&L Gates, Culture, Private law, Principal, Lawyer, Partner

Mitchell Sandler PLLC, a majority-women-owned and women-managed law firm focused on financial services and civil litigation, celebrates its five-year anniversary this month by adding two industry leaders to its Fair Lending Practice Group.

Key Points: 
  • Mitchell Sandler PLLC, a majority-women-owned and women-managed law firm focused on financial services and civil litigation, celebrates its five-year anniversary this month by adding two industry leaders to its Fair Lending Practice Group.
  • Jon Seward and Olivia Kelman are joining the firm’s multidisciplinary team of financial services attorneys and compliance professionals that advise banks, credit unions, independent mortgage companies and fintechs on regulatory, enforcement and litigation matters.
  • As a respected civil rights attorney, Seward built a reputation for being tough but fair in the dozens of cases he oversaw as Principal Deputy of the Housing Section.
  • Kelman joins Mitchell Sandler as a Partner in the firm’s Fair Lending Practice Group.

New Study by Invent Together Finds Building Trust Is Key Driver for Inventing and Patenting, Especially for Women and People of Color

Retrieved on: 
Mittwoch, Mai 1, 2024
DEI (Diversity, Equity and Inclusion), Public Policy, Government, Technology, Consumer, Mobile, Wireless, Start-Up, Patent Law, Business, Small Business, Legal, Human Resources, Science, University, Primary, Secondary, Professional Services, Education, White House, Federal Government, Women, Other Technology, Telecommunications, Other Science, Research, Invention, Small business, Woman, Ecosystem, Element, Technology transfer, Trust, Workplace, History, Patent, Principal, Face, Creativity, Small Business Administration, Role, Organization, Knowledge, K-12, Pharmaceutical industry

The study also identified significant trust gaps among women and people of color, which deter their participation in inventing and patenting.

Key Points: 
  • The study also identified significant trust gaps among women and people of color, which deter their participation in inventing and patenting.
  • Black and Hispanic women are at the greatest disadvantage, with 88% of Hispanic and 86% of Black women reporting minimal or no knowledge.
  • Purpose-driven innovation: Women and people of color are often motivated to invent to benefit their communities or solve a societal problem.
  • This study will help stakeholders better understand and address the complex dynamics influencing engagement in inventing and patenting.

Zuora Appoints John D. Harkey, Jr. to Board of Directors

Retrieved on: 
Mittwoch, Mai 1, 2024
Software, Technology, Professional Services, Business, Agreement, University, Investment, LP, Audit committee, Principal, Therapy, Novartis, Moses Austin, Novartis Gene Therapies, Management

Zuora, Inc. (NYSE: ZUO), a leading monetization suite for modern business, today announced the appointment of John D. Harkey, Jr. to the Zuora Board of Directors, effective April 30, 2024.

Key Points: 
  • Zuora, Inc. (NYSE: ZUO), a leading monetization suite for modern business, today announced the appointment of John D. Harkey, Jr. to the Zuora Board of Directors, effective April 30, 2024.
  • With the addition of Mr. Harkey, the Zuora Board of Directors will consist of ten Board members, nine of whom are independent.
  • Over the course of his career, Mr. Harkey has previously served on the board of directors of nine public companies.
  • Mr. Harkey currently serves on the Board of Directors and Audit Committee of Lionsgate Entertainment Corp., is the Chairman of the Board of Directors of Dialectic Therapeutics, Inc., and Chairman of the Board of Veterinary Service, Inc. Mr. Harkey received his B.B.A.

Renovion Announces Positive Top-Line Results from Phase 2 CLIMB Study of ARINA-1 (RVN-301) in Patients with Non-Cystic Fibrosis Bronchiectasis

Retrieved on: 
Dienstag, April 30, 2024
Health, Infectious Diseases, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Hemoptysis, MCID, Inflammation, Safety, Mucus, QOL, Professor, Bronchiectasis, MD, Doctor of Philosophy, Conference, Mycobacterium, Sputum, Periodic breathing, Urinary tract infection, CAAT, Disease, Chronic cough, Patient, Principal, Aes, Diagnosis, Inc., ITT, American Thoracic Society, Quality of life, Asthma, Bronchitis, National Jewish Health, Division, Infection, COPD, Pharmaceutical industry

The CLIMB study was a randomized double-blind placebo-controlled study to assess the safety and efficacy of ARINA-1 in NCFBE.

Key Points: 
  • The CLIMB study was a randomized double-blind placebo-controlled study to assess the safety and efficacy of ARINA-1 in NCFBE.
  • Participants were randomized (7:3, treatment:placebo), and 40 participants completed the study, with 29 completing in the ARINA-1 arm and 11 in the placebo (0.9% saline) arm.
  • Topline results from the intention-to-treat (ITT) population demonstrate that ARINA-1 is safe and improves quality of life (QOL) in individuals with NCFBE who experience mucus symptoms.
  • Renovion will discuss study results at the American Thoracic Society Meeting (May 17-22) and present findings at the World Bronchiectasis Conference (July 4-6) in Dundee, Scotland.

Sunnova Reports First Quarter 2024 Financial Results

Retrieved on: 
Mittwoch, Mai 1, 2024
Other Energy, Utilities, Construction & Property, Oil, Gas, Batteries, Energy, Technology, Other Construction & Property, P&I, GAAP, Sunnova, NOVA, Investment, ITC, SREC, Professional, Principal, Face, PPA, Bank statement, Adjustment, Interest

Sunnova Energy International Inc. ("Sunnova") (NYSE: NOVA), a leading adaptive energy services company, today announced financial results for the first quarter ended March 31, 2024.

Key Points: 
  • Sunnova Energy International Inc. ("Sunnova") (NYSE: NOVA), a leading adaptive energy services company, today announced financial results for the first quarter ended March 31, 2024.
  • As of March 31, 2024, Sunnova had total cash of $487.5 million, including restricted and unrestricted cash.
  • As Sunnova re-focuses on its core adaptive energy customers it now expects full year 2024 customer additions to fall between 140,000 and 150,000.
  • Sunnova is hosting a conference call for analysts and investors to discuss its first quarter 2024 results at 8:00 a.m. Eastern Time, on May 2, 2024.

Southern California NIRI Chapters and Nasdaq Host the 2nd Annual NIRI SoCal Conference

Retrieved on: 
Dienstag, April 30, 2024
Professional Services, Business, Communications, Finance, Consulting, Public Relations, Investor Relations, CFO, Business Wire, Conference, Vizio, SVP, Principal, S&P Global, Rivel, IRC, Computershare, NIRI

The Southern California chapters of the NIRI (the association for investor relations) and Nasdaq will co-host the second annual NIRI SoCal Regional Conference titled, “Seizing the Evolving Dynamics in Investor Relations.” Corporate executives in investor relations, finance, and corporate affairs will gather for this one-day event to learn from experts and share experiences on the latest issues and trends in financial, investor, and corporate communications.

Key Points: 
  • The Southern California chapters of the NIRI (the association for investor relations) and Nasdaq will co-host the second annual NIRI SoCal Regional Conference titled, “Seizing the Evolving Dynamics in Investor Relations.” Corporate executives in investor relations, finance, and corporate affairs will gather for this one-day event to learn from experts and share experiences on the latest issues and trends in financial, investor, and corporate communications.
  • Location: UCI Beall Applied Innovation Center, Irvine, CA
    Early Bird pricing is available through May 3, 2024!
  • Moderated by John Moten, IRC, SVP Investor Relations, Aventiv Technologies & Chair of NIRI, with:
    Sanya Badr, Principal & IR Search Practice Leader, Crist|Kolder Associates
    Adam Townsend, CFO and Head of IR, Vizio
    Along with Nasdaq as the co-host and headline sponsor, additional sponsors include Broadridge, Morrow Sodali, Riveron, Irwin, S&P Global, Computershare, Rivel, Stakeholder Labs, Business Wire, Pondel Wilkinson, Virtua, and the Buddy Group.

LearnUpon Certified as Smartchoice® Preferred Provider by Brandon Hall Group

Retrieved on: 
Donnerstag, April 11, 2024
Heart, LMS, Certification, Learning, Principal, Organization, Knowledge, HCM, Tourism

“LearnUpon’s intuitive platform makes it easy to support any audience - whether it's employees, partners, or customers - with training anytime, anywhere,” said Michael Rochelle, Chief Strategy Officer and Principal HCM Analyst at Brandon Hall Group.

Key Points: 
  • “LearnUpon’s intuitive platform makes it easy to support any audience - whether it's employees, partners, or customers - with training anytime, anywhere,” said Michael Rochelle, Chief Strategy Officer and Principal HCM Analyst at Brandon Hall Group.
  • “LearnUpon empowers the world’s most innovative companies to build better experiences by supporting learning across their entire business network.”
    The analyst team at Brandon Hall Group has spent a considerable amount of time understanding LearnUpon and the market they operate.
  • Brandon Hall Group’s Smartchoice® Preferred Provider Program provides a world-class membership center for knowledge, resources, and advisory support to the entire LearnUpon organization to ensure our certification reflects the highest standards a Provider can attain in the market.
  • “We’re delighted Brandon Hall Group has certified LearnUpon as a Smartchoice® Preferred Provider, recognizing the role we play in partnering with our customers, putting training at the heart of their growth strategy,” said Brendan Noud, CEO, and co-founder of LearnUpon.

Auto Parts 4 Less Group Inc. Announces Strategic Investment from RB Capital to Fuel Growth and Innovation

Retrieved on: 
Donnerstag, April 11, 2024
O'Reilly Auto Parts, OTC, Partnership, Principal, FLES, Management

LAS VEGAS, April 11, 2024 (GLOBE NEWSWIRE) -- Auto Parts 4 Less Group Inc. (OTC: FLES) ("AutoParts4Less," "the Company"), a technology-driven e-commerce leader in the automotive parts sector, announces investment from RB Capital.

Key Points: 
  • LAS VEGAS, April 11, 2024 (GLOBE NEWSWIRE) -- Auto Parts 4 Less Group Inc. (OTC: FLES) ("AutoParts4Less," "the Company"), a technology-driven e-commerce leader in the automotive parts sector, announces investment from RB Capital.
  • Christopher Davenport, CEO of Auto Parts 4 Less Group Inc., stated, "We are thrilled to partner with RB Capital in this exciting new chapter for AutoParts4Less.
  • RB Capital, under the leadership of Brett Rosen, has agreed to invest in Auto Parts 4 Less Group Inc.
  • Brett Rosen, Principal of RB Capital, stated: "We are excited to support Auto Parts 4 Less Group Inc. as they continue to innovate and grow.

ViGeneron Announces First Patient Dosed in Phase 1b Clinical Trial of VG901 for the Intravitreal Treatment of Retinitis Pigmentosa

Retrieved on: 
Mittwoch, April 10, 2024
University, Ophthalmology, Retinitis pigmentosa, Risk, Hope, Safety, IVT, Clinic, Patient, Principal, Eye, CNGA1, Clinical trial, Phases of clinical research, Pharmaceutical industry

This milestone marks an important advance as the company continues to leverage its next-generation technology platforms to develop groundbreaking gene therapies addressing critical unmet medical needs.

Key Points: 
  • This milestone marks an important advance as the company continues to leverage its next-generation technology platforms to develop groundbreaking gene therapies addressing critical unmet medical needs.
  • VG901 has also been granted FDA Orphan Drug Designation status.
  • We look forward to progressing the clinical development of this potentially transformative therapy,” said Dr. Caroline Man Xu, ViGeneron’s Co-founder and CEO.
  • For more information on the trial, please visit clinicaltrial.gov [ NCT06291935 ].